ÂÜÀòÂÒÂ×

Lynne Cesario has extensive experience in the pharmaceutical industry, currently serving as Executive Director and Senior Director at Pfizer since July 1997, where responsibilities include leading the Global Risk Based Monitoring Program with a focus on process definition, technology implementation, training, and global Central Monitoring initiatives. Additionally, Lynne serves as the RBM Workstream Lead at TransCelerate BioPharma Inc. since June 2019 and has previously held the role of Information Strategist for a large Phase III program in the CV/MED therapeutic area. Lynne's educational background includes an MBA from the University of Phoenix and a BS in Math/Statistics and Biology from the University of Mary Washington, along with ongoing studies at Yale University and Brown University.